Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The forecast for this week
Criticism has been voiced at the plans for the creation of a traveller site, but a charity representing travellers has defended the council.
As Entertainment Corespondent I've been lucky enough to interview Cilla many times. I found her a charming lady, says Caroline Whitmore.